A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial disease.
D000328:Adult; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D011464:Epoprostenol / Q000627:therapeutic use*; D005260:Female; D006439:Hemodynamics; D006801:Humans; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000523:psychology; D010979:Platelet Function Tests; D011453:Prostaglandins / Q000627:therapeutic use*; D011897:Random Allocation; D012039:Regional Blood Flow / Q000187:drug effects
D011453:Prostaglandins; D011464:Epoprostenol